Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION

v3.6.0.2
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2016
STOCK-BASED COMPENSATION [Abstract]  
STOCK-BASED COMPENSATION
NOTE 11 – STOCK-BASED COMPENSATION

The Company has stock-based compensation plans for its employees (the Employees’ Plans) and directors (the Directors’ Plans).  The Employees’ Plans permit the grant of stock options or the issuance of restricted stock for up to 1,917,210 shares of common stock.  The Directors’ Plans permit the grant of stock options or the issuance of restricted stock for up to 473,278 shares of common stock.  Issuance from these plans was curtailed in 2015.  On May 5, 2015, the Company’s shareholders approved the Macatawa Bank Corporation Stock Incentive Plan of 2015 (the 2015 Plan).  The 2015 Plan provides for grant of up to 1,500,000 shares of Macatawa common stock in the form of stock options or restricted stock  awards to employees and directors. There were 1,365,975 shares under the “2015 Plan” available for future issuance as of December 31, 2016.  The Company issues new shares under its stock-based compensation plans from its authorized but unissued shares.

Stock Options

Option awards are granted with an exercise price equal to the market price at the date of grant.  Option awards have vesting periods ranging from one to three years and have ten year contractual terms.

The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model.  Expected volatilities are based on historical volatilities of the Company’s common stock.  The Company uses historical data to estimate option exercise and post-vesting termination behavior.  The expected term of options granted is based on historical data and represents the period of time that options granted are expected to be outstanding, which takes into account that the options are not transferable.  The Company expects that all options granted will vest and become exercisable. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

There were no options granted during 2016, 2015 and 2014.  A summary of option activity in the plans is as follows (dollars in thousands, except per option data):
 
Options
 
Number
Outstanding
   
Weighted-
Average
Exercise Price
   
Weighted-
Average
Remaining
Contractual
Life in Years
   
Aggregate
Intrinsic Value
 
Outstanding at January 1, 2016
   
102,299
   
$
13.04
     
---
     
---
 
Forfeited
   
(8,000
)
   
8.57
     
---
     
---
 
Expired
   
(41,299
)
   
19.64
     
---
     
---
 
Outstanding at December 31, 2016
   
53,000
   
$
8.57
     
1.05
   
$
97,520
 
                                 
Exercisable at December 31, 2016
   
53,000
   
$
8.57
     
1.05
   
$
97,520
 

Information related to stock options during each year follows (dollars in thousands):
 
   
2016
   
2015
   
2014
 
Intrinsic value of options exercised
 
$
---
   
$
---
   
$
---
 
Cash received from option exercises
   
---
     
---
     
---
 
Tax benefit realized from option exercises
   
---
     
---
     
---
 

There was no compensation cost for stock options in 2016, 2015 and 2014.

As of December 31, 2016, there was no unrecognized cost related to nonvested stock options granted under the Company’s stock-based compensation plans.
 
Restricted Stock Awards

Restricted stock awards have vesting periods of up to three years.  A summary of changes in the Company’s nonvested restricted stock awards for the year follows:
 
Nonvested Stock Awards
 
Shares
   
Weighted-
Average
Grant-Date Fair
Value
   
Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2016
   
197,846
   
$
5.34
   
$
1,196,968
 
Granted
   
46,025
     
9.67
     
479,120
 
Vested
   
(111,323
)
   
5.28
     
1,158,872
 
Forfeited
   
---
     
---
     
---
 
Outstanding at December 31, 2016
   
132,548
   
$
6.88
   
$
1,379,825
 

Compensation cost related to restricted stock awards totaled $536,000, $478,000 and $338,000 for 2016, 2015 and 2014, respectively.

As of December 31, 2016, there was $864,000 of total remaining unrecognized compensation cost related to nonvested restricted stock awards granted under the Company’s stock-based compensation plans.  The cost is expected to be recognized over a weighted-average period of 1.46 years.  The total grant date fair value of restricted stock awards vested during 2016 was $588,000.  The total grant date fair value of restricted stock awards vested during 2015 was $471,000.  The total grant date fair value of restricted stock awards vested during 2014 was $299,000.